Literature DB >> 15166088

The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor.

Jyotsna Pandey1, Anas Bannout, Douglas L Wendell.   

Abstract

Edpm5 is one member of a group of quantitative trait loci that are responsible for the difference in susceptibility to estrogen-induced prolactinoma between the Fischer 344 (F344) and Brown Norway (BN) strains. Upon chronic estrogen treatment F344 rats develop large, hemorrhagic and invasive pituitary tumors, which exhibit both tumor angiogenesis and neoplasia. In contrast, BN rats do not develop a tumor despite an estrogen-induced increase in lactotroph density. To investigate the role of Edpm5 in the development of these tumors, we have generated a novel congenic rat strain F344.BN-Edpm5BN by introgressing the segment of rat chromosome bearing Edpm5 from BN into the F344 strain background. Phenotypic differences between F344 and F344.BN-Edpm5BN must be due to a gene(s) within the chromosomal interval encompassing Edpm5. Through use of these strains, we find that Edpm5 specifically regulates the switch to angiogenic phenotype, independent of neoplasia. The F344.BN-Edpm5BN rats developed tumors, which exhibited significant growth, 7-fold greater mass than the pituitary of untreated rats, and neoplasia indistinguishable from that of the F344 strain. However, the F344.BN-Edpm5BN rat tumor had a non-angiogenic phenotype. After chronic estrogen treatment, there was no increase in microvessel count over untreated controls in F344.BN-Edpm5BN tumors, whereas F344 rat tumors showed a significant increase (P < 0.0005). The ultrastructural morphology of the pituitary blood vessels also did not show significant angiogenesis associated changes in F344.BN-Edpm5BN rat pituitary tumors. In contrast the parental strain F344 had pronounced angiogenic activity. The F344.BN-Edpm5BN strain also fails to express VEGF at the high levels seen in the F344 rat pituitary after estrogen treatment. Hence at least one gene that has a large impact, directly or indirectly, on the switch to angiogenic phenotype must reside within the chromosomal interval that is the Edpm5 quantitative trait locus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166088     DOI: 10.1093/carcin/bgh192

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat.

Authors:  Douglas L Wendell; Adrian Platts; Susan Land
Journal:  J Steroid Biochem Mol Biol       Date:  2006-09-26       Impact factor: 4.292

Review 2.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Localization of Eutr2, a locus controlling susceptibility to DES-induced uterine inflammation and pyometritis, to RNO5 using a congenic rat strain.

Authors:  Jyotsna Pandey; Karen A Gould; Rodney D McComb; James D Shull; Douglas L Wendell
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

4.  Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains.

Authors:  Tracy E Strecker; Thomas J Spady; Beverly S Schaffer; Karen A Gould; Amy E Kaufman; Fangchen Shen; Mac T McLaughlin; Karen L Pennington; Jane L Meza; James D Shull
Journal:  Genetics       Date:  2005-01-31       Impact factor: 4.562

5.  Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.

Authors:  James D Shull; Cynthia M Lachel; Clare R Murrin; Karen L Pennington; Beverly S Schaffer; Tracy E Strecker; Karen A Gould
Journal:  Mamm Genome       Date:  2007-09-18       Impact factor: 2.957

6.  Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat.

Authors:  Scott G Kurz; Kimberly K Hansen; Mac T McLaughlin; Vijay Shivaswamy; Beverly S Schaffer; Karen A Gould; Rodney D McComb; Jane L Meza; James D Shull
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

Review 7.  Common polymorphisms in angiogenesis.

Authors:  Michael S Rogers; Robert J D'Amato
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 8.  Genetic variation in sensitivity to estrogens and breast cancer risk.

Authors:  D Joseph Jerry; James D Shull; Darryl L Hadsell; Monique Rijnkels; Karen A Dunphy; Sallie S Schneider; Laura N Vandenberg; Prabin Dhangada Majhi; Celia Byrne; Amy Trentham-Dietz
Journal:  Mamm Genome       Date:  2018-02-27       Impact factor: 2.957

9.  Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3.

Authors:  Jyotsna Pandey; Douglas L Wendell
Journal:  Mamm Genome       Date:  2006-01-13       Impact factor: 3.224

10.  Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases.

Authors:  Kirsten L Dennison; Aaron C Chack; Maureen Peters Hickman; Quincy Eckert Harenda; James D Shull
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.